Novo Nordisk unveils Wegovy sales
![Photo: Jacob Gronholt-Pedersen/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13969995.ece/ALTERNATES/schema-16_9/20220202-133226-1-6720x3772ma.jpg)
Since launching obesity treatment Wegovy on the US market in June of last year, Novo Nordisk has not wanted to report on individual sales within its Obesity Care business.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk subsupplier reinitiates Wegovy production
For subscribers
Novo Nordisk more than doubles 2025 obesity sales goal
For subscribers
Novo CFO: Obesity market is difficult to predict
For subscribers